French Drugmaker
- All
- News
- Videos
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Trouble Mounts For Dengue Vaccine Over Safety Concerns
The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases.
-
Google Parent Alphabet and French Drugmaker Sanofi Set Up Diabetes Joint Venture
The venture, called Onduo, will initially focus on type two diabetes, the more common form of the disease.
-
Sanofi, Google Parent In $500 Million Diabetes Joint Venture
French drugmaker Sanofi and Google owner Alphabet's U.S-based life sciences company Verily, announced on Monday the launch of a joint-venture aimed at offering patients suffering from diabetes products that will combine devices and services.
-
Painkiller Combiflam Runs Into Trouble, Some Batches Withdrawn
The popular painkiller Combiflam is being withdrawn in batches in India after the country's drugs regulator found the lots were substandard, said the local unit of French drugmaker Sanofi.
-
Indebted Tycoon Vijay Mallya To Step Down As Sanofi India Chairman
Indian business tycoon Vijay Mallya, under pressure from banks to repay more than dollar 1 billion owed by his collapsed airline, has decided to not seek re-election as chairman of French drugmaker Sanofi's India unit, the company said.
-
World's first dengue vaccine beats three virus strains
The world's first vaccine against dengue, developed by French drugmaker Sanofi SA, has shown the ability to protect against disease caused by three of four virus strains in a keenly awaited clinical trial in Thailand.
-
Cipla loses PetArmor case in US appeals court
The PetArmor Plus brand is owned by Merial Ltd, a unit of French drugmaker Sanofi, and is used to treat fleas in cats and dogs.
-
Gap between petrol-diesel prices should be cut by 30%: Pawan Goenka
The PetArmor Plus brand is owned by Merial Ltd, a unit of French drugmaker Sanofi, and is used to treat fleas in cats and dogs.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Trouble Mounts For Dengue Vaccine Over Safety Concerns
The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases.
-
Google Parent Alphabet and French Drugmaker Sanofi Set Up Diabetes Joint Venture
The venture, called Onduo, will initially focus on type two diabetes, the more common form of the disease.
-
Sanofi, Google Parent In $500 Million Diabetes Joint Venture
French drugmaker Sanofi and Google owner Alphabet's U.S-based life sciences company Verily, announced on Monday the launch of a joint-venture aimed at offering patients suffering from diabetes products that will combine devices and services.
-
Painkiller Combiflam Runs Into Trouble, Some Batches Withdrawn
The popular painkiller Combiflam is being withdrawn in batches in India after the country's drugs regulator found the lots were substandard, said the local unit of French drugmaker Sanofi.
-
Indebted Tycoon Vijay Mallya To Step Down As Sanofi India Chairman
Indian business tycoon Vijay Mallya, under pressure from banks to repay more than dollar 1 billion owed by his collapsed airline, has decided to not seek re-election as chairman of French drugmaker Sanofi's India unit, the company said.
-
World's first dengue vaccine beats three virus strains
The world's first vaccine against dengue, developed by French drugmaker Sanofi SA, has shown the ability to protect against disease caused by three of four virus strains in a keenly awaited clinical trial in Thailand.
-
Cipla loses PetArmor case in US appeals court
The PetArmor Plus brand is owned by Merial Ltd, a unit of French drugmaker Sanofi, and is used to treat fleas in cats and dogs.
-
Gap between petrol-diesel prices should be cut by 30%: Pawan Goenka
The PetArmor Plus brand is owned by Merial Ltd, a unit of French drugmaker Sanofi, and is used to treat fleas in cats and dogs.
